Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics

• URL: http://arxiv.org/abs/2005.11248v2
• Date: Fri, 26 Feb 2021 01:03:38 GMT
• Title: Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics
• Authors: Payel Das, Tom Sercu, Kahini Wadhawan, Inkit Padhi, Sebastian Gehrmann, Flaviu Cipcigan, Vijil Chenthamarakshan, Hendrik Strobelt, Cicero dos Santos, Pin-Yu Chen, Yi Yan Yang, Jeremy Tan, James Hedrick, Jason Crain, Aleksandra Mojsilovic
• Abstract summary: CLaSS (Controlled Latent attribute Space Sampling) is an efficient computational method for attribute-controlled generation of molecules. We screen the generated molecules for additional key attributes by using deep learning classifiers in conjunction with novel features derived from atomistic simulations. The proposed approach is demonstrated for designing non-toxic antimicrobial peptides (AMPs) with strong broad-spectrum potency.
• Score: 109.70543391923344
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: De novo therapeutic design is challenged by a vast chemical repertoire and multiple constraints, e.g., high broad-spectrum potency and low toxicity. We propose CLaSS (Controlled Latent attribute Space Sampling) - an efficient computational method for attribute-controlled generation of molecules, which leverages guidance from classifiers trained on an informative latent space of molecules modeled using a deep generative autoencoder. We screen the generated molecules for additional key attributes by using deep learning classifiers in conjunction with novel features derived from atomistic simulations. The proposed approach is demonstrated for designing non-toxic antimicrobial peptides (AMPs) with strong broad-spectrum potency, which are emerging drug candidates for tackling antibiotic resistance. Synthesis and testing of only twenty designed sequences identified two novel and minimalist AMPs with high potency against diverse Gram-positive and Gram-negative pathogens, including one multidrug-resistant and one antibiotic-resistant K. pneumoniae, via membrane pore formation. Both antimicrobials exhibit low in vitro and in vivo toxicity and mitigate the onset of drug resistance. The proposed approach thus presents a viable path for faster and efficient discovery of potent and selective broad-spectrum antimicrobials.

Related papers

• BetterBodies: Reinforcement Learning guided Diffusion for Antibody Sequence Design [10.6101758867776]
  Antibodies offer great potential for the treatment of various diseases. The discovery of therapeutic antibodies through traditional wet lab methods is expensive and time-consuming. The use of generative models in designing antibodies holds great promise, as it can reduce the time and resources required.
  arXiv  Detail & Related papers  (2024-09-09T13:06:01Z)
• Artificial intelligence-driven antimicrobial peptide discovery [0.0]
  Antimicrobial peptides (AMPs) emerge as promising agents against antimicrobial resistance. AMPs provide an alternative to conventional antibiotics. Artificial intelligence (AI) revolutionized AMP discovery through both discrimination and generation approaches.
  arXiv  Detail & Related papers  (2023-08-21T14:02:14Z)
• Random Copolymer inverse design system orienting on Accurate discovering of Antimicrobial peptide-mimetic copolymers [9.416757363901295]
  We develop a universal random copolymer inverse design system via multi-model copolymer representation learning, knowledge distillation and reinforcement learning. By pre-training a scaffold-decorator generative model via knowledge distillation, copolymer space are greatly contracted to the near space of existing data for exploration. Our reinforcement learning algorithm can be adaptive for customized generation on specific scaffolds and requirements on property or structures.
  arXiv  Detail & Related papers  (2022-11-30T14:29:50Z)
• xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
  We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence. The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
  arXiv  Detail & Related papers  (2022-11-30T09:26:08Z)
• Accelerating Antimicrobial Peptide Discovery with Latent Structure [33.288514128470425]
  We propose a latent sequence-structure model for designing AMPs (LSSAMP) LSSAMP exploits multi-scale vector quantization in the latent space to represent secondary structures. Experimental results show that the peptides generated by LSSAMP have a high probability of antimicrobial activity.
  arXiv  Detail & Related papers  (2022-11-28T06:43:32Z)
• Graph-Based Active Machine Learning Method for Diverse and Novel Antimicrobial Peptides Generation and Selection [57.131117785001194]
  Large-scale screening of new AMP candidates is expensive, time-consuming, and now affordable in developing countries. We propose a novel active machine learning-based framework that statistically minimizes the number of wet-lab experiments needed to design new AMPs.
  arXiv  Detail & Related papers  (2022-09-18T14:30:48Z)
• Accelerating Inhibitor Discovery for Multiple SARS-CoV-2 Targets with a Single, Sequence-Guided Deep Generative Framework [47.14853881703749]
  We demonstrate the broad utility of a single deep generative framework toward discovering novel drug-like inhibitor molecules. To perform target-aware design, the framework employs a target sequence-conditioned sampling of novel molecules from a generative model. The most potent spike RBD inhibitor also emerged as a rare non-covalent antiviral with broad-spectrum activity against several SARS-CoV-2 variants.
  arXiv  Detail & Related papers  (2022-04-19T17:59:46Z)
• Optimizing Molecules using Efficient Queries from Property Evaluations [66.66290256377376]
  We propose QMO, a generic query-based molecule optimization framework. QMO improves the desired properties of an input molecule based on efficient queries. We show that QMO outperforms existing methods in the benchmark tasks of optimizing small organic molecules.
  arXiv  Detail & Related papers  (2020-11-03T18:51:18Z)
• CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models [74.58583689523999]
  We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins. CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme. CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
  arXiv  Detail & Related papers  (2020-04-02T18:17:20Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.